| COVID-19 |
1 |
1 |
| California |
0 |
0.21 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.8 |
| Acute Respiratory Distress Syndrome |
0 |
0.2 |
| Digital of Foot |
0 |
0.5 |
| Pandemic |
0 |
0.14 |
| Adolescent Medicine |
0 |
0.45 |
| Child |
0 |
0.3 |
| Dermatitis |
0 |
0.45 |
| Dorsum |
0 |
0.05 |
| Systemic Lupus Erythematosus |
0 |
0.5 |
| Rheumatoid Arthritis |
0 |
0.65 |
| Antiphospholipid Syndrome |
0 |
0.55 |
| Arthritis |
0 |
0.02 |
| Europe |
0 |
0.02 |
| Hand |
0 |
0.02 |
| Hyperhidrosis |
0 |
0.45 |
| Id Reaction |
0 |
0.02 |
| Immunoglobulin A (IgA) |
0 |
0.02 |
| Leukemia |
0 |
0.3 |
| Lupus |
0 |
0.02 |
| Lymphoma |
0 |
0.3 |
| Pedal |
0 |
0.02 |
| Skin Rash |
0 |
0.02 |
| Viral Infection |
0 |
0.02 |